Panax japonicas C. A. Mey.

Zingibroside R1 is an orally active triterpene saponin with multiple biological activities including antioxidant, anti-inflammatory, antiviral, and metabolic regulatory properties. Zingibroside R1 reduces the expression of PIN family members, inhibits the expression of PLT1/PLT2, WOX5, SHR, and SCR, disrupts auxin transport and distribution, triggers plant ROS responses, and inhibits root growth. Zingibroside R1 extends the lifespan of Caenorhabditis elegans, enhances its heat stress resistance, and improves its motor ability. Hydrogel derivatives of Zingibroside R1 inhibit the proliferation of Candida albicans by binding to its β-1,3-glucan and exhibit antifungal activity. Zingibroside R1 inhibits GLUT1-mediated uptake and alleviates liver injury. Zingibroside R1 can be used in research related to neurodegenerative diseases, vulvovaginal candidiasis, acute liver injury, Ehrlich ascites tumor and HIV-1 infection.

Panaxjapyne A is a baker's yeast α-glucosidase inhibitor with an IC₅₀ of 71.82 μM. Panaxjapyne A can be used in diabetes-related research.

Panax japonicus polysaccharide is a polysaccharide derived from Panax japonicus.

Chikusetsusaponin FK6 is a dammarane-type triterpenoid saponin that can be found in the fruits of Panax japonicus C. A. MEYER.

Panaxjapyne B is a polyacetylene compound. Panaxjapyne B can be isolated from roots of P. japonicus var. major.